Evaluation of the epidemiological, clinical and laboratory findings in continuous ambulatory peritoneal dialysis related peritonitis attacks;Sürekli ayaktan periton diyalizi ile ilişkili peritonit ataklarιnda epidemiyolojik, klinik ve laboratuvar bulgularιnιn deǧerlendirilmesi

Mikrobiyoloji Bulteni

Volumn 42, Issue 2, 2008, Pages 255-264

  Bulut, Cemal ^a   Öztürk, Reyhan ^a   Yilmaz, Gül Ruhsar ^a   Parpucu, Hülya ^b   Irmak, Hasan ^a   Kinikli, Sami ^a   Duranay, Murat ^b   Demiröz, Ali Pekcan ^a  

^a Enfeksiyon Hastaliklari ve Klinik Mikrobiyoloji Klini i   (Turkey)

^b Nefroloji Kliniǧi ^*  (Turkey)

Author keywords

Clinical symptoms; Continuous ambulatory peritoneal dialysis; Laboratory findings; Peritonitis

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; ASCITES FLUID; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CYTOLOGY; FEMALE; HUMAN; INCIDENCE; LEUKOCYTE COUNT; MALE; MICROBIOLOGY; MIDDLE AGED; PERITONITIS; TURKEY (REPUBLIC);

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ASCITIC FLUID; FEMALE; HUMANS; INCIDENCE; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PERITONITIS; TURKEY; YOUNG ADULT;

EID: 52349119128     PISSN: 03749096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Gokal R. History of peritoneal dialysis, pp: 1-17. In: Gokal R, Khanna R, Krediet T, Nolph KD (eds), The Textbook of Peritoneal Dialysis, 2000, 2nd ed. Kluwer Academic Publishers, UK.
2. Erek E, Süleymanlar G, Serdengeçti K. Türkiye'de Nefroloji: Dializ ve Transplantasyon. 1997. Türk Nefroloji Derneǧi Yayinlari, Istanbul.
3. Gokal R. Taking peritoneal dialysis beyond the year 2000. Perit Dial Int 1999; 19 (Suppl 3): 35-42.
4. Türk Nefroloji Derneǧi. Merkez Bilgileri Dönem 2003. http://www.tsn.org.tr./registery.asp.
5. Fried L, Piraino B. Peritonitis, pp: 545-60. In: Gokal R, Khanna R, Krediet T, Nolph KD (eds), The Textbook of Peritoneal Dialysis. 2000, 2nd ed. Kluwer Academic Publishers, UK.
6. Keane W, Bailie GR, Boeschoten E, et al.: International Society for Peritoneal Dialysis. Adult peritoneal dialysis-related peritonitis treatment recommendations: 2000 update. Perit Dial Int 2000; 20: 396-411.
7. Kaya M, Altintepe L, Baysal B, Güney I, Türk S, Tonbul Z. SAPD peritonitinde kültür pozitiflik orani ve tedavi sonuçlari. Türk Nefroloji Diyaliz ve Transplantasyon Derg 2005; 14:132-5.
8. Rubin J, Rogers WA, Taylor HM. Peritonitis during continuous ambulatory peritoneal dialysis. Ann Intern Med 1980; 92: 7-13.
9. Tekin Koruk S, Yetkin MA, Koruk I ve ark. Sürekli ayaktan periton diyalizi uygulanan hastalarda gelişen peritonit ataklarininin deǧerlendirilmesi. Flora 2006; 11: 24-31.
10. Kim DK, Ryu DR, Xu ZG, et al. Changes in causative organisms and their antimicrobial susceptibilities in CAPD peritonitis: a single center's experience over one decade. Perit Dial Int 2004; 24: 424-32.
11. Golper TA, Brier ME, Bunke M, et al. Risk factors for peritonitis in long-term peritoneal dialysis: the Network 9 peritonitis and catheter survival studies. Academic Subcommittee of the Steering Committee of the Network 9 Peritonitis and Catheter Survival Studies. Am J Kidney Dis 1996; 28: 428-36.
12. Carmona AR, Fontan MP, Falcon TG, Rivera CF, Valdes F. A comparative analysis on the incidence of peritonitis and exit-site infection in CAPD and automated peritoneal dialysis. Perit Dial Int 1999; 19: 253-8.
13. Lupo A, Tarchini R, Cancarini G, Catizone L. Long term outcome in continuous ambulatory peritoneal dialysis: a 10-year survey by the Italian cooperative peritoneal dialysis study group. Am J Kidney Dis 1994; 24: 826-37.
14. Troidle L, Finkelstein F. Treatment and outcome of CAPD-associated peritonitis. Ann Clin Microbiol Antimicrob 2006; 5: 1-7.
15. Szeto CC, Chow KM. The changing face of peritonitis. Perit Dial Int 2004; 24: 413-5.
16. Borawski J, Mysliwiec M. The hematocrit-corrected erythrocyte sedimentation rate can be useful in diagnosing inflammation in hemodialysis; patients. Nephron 2001; 89: 381-3.
17. Fine A. Relevance of C-reactive protein levels in peritoneal dialysis patients. Kidney Int 2002; 61: 615-20.
18. Dahaba AA, Rehak PH, List WF. Procalcitonin and C-reactive protein plasma concentration in nonseptic uremic patients undergoing hemodialysis. Intensive Care Med 2003; 29: 579-83.
19. Hind CR, Thomson SP, Winearls CG, Pepys MB. Serum C-reactive protein concentration in the management of infection in patients treated by continuous ambulatory peritoneal dialysis. J Clin Pathol 1985; 38: 459-63.
20. Tiroidle L, Kligger A, Gorban-Brennan N, Finkelstein F. Course of C-reactive protein during continuous peritoneal dialysis-associated peritonitis. Nephrology (Carlton) 2005; 10: 442-5.
21. Opatrna S, Klaboch J, Opatrny K, et al. Procalcitonin levels in peritoneal dialysis patients. Perit Dial Int 2005; 25: 470-2.
22. Güz G, Colak B, Hizel K, et al. Procalcitonin and conventional markers of inflammation in peritoneal dialysis patients and peritonitis. Perit Dial Int 2006; 26: 240-8.
23. Taylor PC. Routine laboratory diagnosis of continuous ambulatory peritoneal dialysis peritonitis using centrifugation and saponin-containing media. Eur J Clin Microbiol Infect Dis 1994; 13: 249-52.
24. Goldberg L, Clemenger M, Azadian B, Brown EA. Initial treatment of peritoneal dialysis peritonitis without vancomycin with a once-daily cefazolin-based regimen. Am J Kidney Dis 2001; 37: 49-55.
25. Golper TA, Hartstein A. Analysis of the causative pathogens in uncomplicated CAPD-associated peritonitis: duration of therapy, relapses and prognosis. Am J Kidney Dis 1986; 7: 141-5.
26. Holley JL, Bernardini J, Johnston JR, Piraino B. Methicillin-resistant staphylococcal infections in an outpatient peritoneal dialysis program. Am J Kidney Dis 1990; 16:142-6.
27. Prasad KN, Prasad N, Gupta A, Sharma RK, Verma AK, Ayyagari A. Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis: a single centre Indian experience. J Infect 2004; 48: 96-101.
28. Chow KM, Szeto CC, Leung CB, Kwan BC; Law MC, Li PK. A risk analysis of continuous ambulatory peritoneal dialysis-related peritonitis. Perit Dial Int 2005; 25: 374-9.
29. Piraino B, Perlmutter JA, Holley JL, Bernardini J. Staphylococcus aureus peritonitis is associated with Staphylococcus aureus nasal carriage peritoneal dialysis patients. Perit Dial Int 1993; 13 (Suppl 2): 332-4.
30. Lye WC, Leong SO, Lee EJ. Staphylococcus aureus CAPD-related infections are associated with nasal carriage. Adv Perit Dial 1994; 10: 163-5.
31. Turner K, Uttley L, Scrimgeour A, McKewan A, Gokal R. Natural history of Staphylococcus aureus nasal carriage and its relationship to exit-site infection, Perit Dial Int 1998; 18: 271-3.